Integrating Psychedelics into Mental Healthcare
Learn More
Annual mental health cost to the UK economy £90bn
17.7% of the population affected by mental health issues annually
5% of the population affected by depression
3% of the population affected by alcohol and drug abuse
Clinical Trials
Delivering independent psychedelic research
Therapeutic Clinics
UK nationwide clinic platform
Practitioner Training
Creating the training standard
Clinical Trials
On-demand research and clinical trials – study design, enrollment, execution – for the medicalisation of psychedelic assisted therapy. Advancing mental health through pre-clinical, Phase I-III, regulatory submissions and IP creation.
– Clinical trial selection: AWAKN will work with our network of public and private stakeholders to identity and fund targeted areas for research.
– Clinical trial delivery: AWAKN will complete targeted clinical trials for the medicalisation of psychedelic assisted therapy.
Therapeutic Clinics
A revolutionary shift in the treatment approach for mental health disorders, under the leadership of psychiatric specialist, researcher, author and clinic founder, Dr. Ben Sessa.
– Highly trained expert clinicians, working with psychedelics under Schedule 2, for the treatment of multiple mental conditions.
– First of its kind psychedelic assisted psychotherapy administered in state-of-the-art clinics, with the first site in the psychedelic hub of the UK, Bristol.
Practitioner Training
Innovative psychedelic training for Psychiatrists and Psychologists to pivot into the future of mental health disorder treatments.
– In person training: Accredited training course for qualified practitioners, usually physiatrists
– Online Continuous Development (CPD) learning: Online full or half day accredited training for all medical practitioners with credits annual CPD targets
Prof. David Nutt
Chairman, Scientific Advisory Board
Dr. Ben Sessa
Chief Medical Officer
Dr. Matthew Johnson
Advisor
Anthony Tennyson
Chief Executive Officer
Jonathan Held
Chief Financial Officer
Dr. Laurie Higbed
Lead Psychologist
Dr. Dawn DeCunha
Advisor
George Scorsis
Chairman, Corporate Board
Dr. Ben Sessa: TEDx
Michael Pollan: Psychedelics solve mental health crisis
Revealing the Mind: The Promise of Psychedelics
Professor David Nutt: TEDx
